NSW government research shows 50 per cent of women experience harassment while running, while 95 per cent say safety issues influence their behaviour. An additional $500,000 has been allocated to the ...

Gen. Stephen Whiting noted the number of personnel at Redstone is expected to grow to nearly 200 by the end of 2026. (Staff Sgt. Kirsten Brandes/U.S. Space Force) U.S. Space Command is operating a ...

Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

FARMINGTON — The Mayo boys basketball team saw its best season in nearly 20 years end in the Section 1, Class 4A semifinals against a familiar foe. It came down to the wire as the No. 3-seeded ...

ESCONDIDO — For the last three years, the CIF San Diego Section Open Division boys soccer title has known no home but the halls of St. Augustine High School. Until now. Behind a first-half score by ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Tuesday night was chalked full of boys’ hockey section playoff action. All eight quarterfinal games have come and gone with eight teams punching their tickets to the semifinals AMSOIL Arena on ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.